SoFi crushed revenue estimates and raised its top-line outlook, yet shares cratered 10% anyway as sellers zeroed in on one number management refused to budge on.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Wall Street expects Qualcomm to report $9.6 billion in revenue and earnings per share of $2.22 for the fiscal third quarter.
QRVO tops Q1 earnings and revenue estimates despite lower smartphone-related sales, as strong growth in High-Performance Analog and disciplined cost management lift margins.
Traders are expecting big swings from tech earnings on Wednesday, with options pricing in major after-market risks and short sellers lining up to bet against one of the market’s biggest stocks. Microsoft shares, which have fallen more than 15% from their early June peak and remain nearly 25% lower over the past year, are likely to move more than 6.6% in either direction after tonight’s June-quarter earnings, well ahead of its three-year average of around 4.8%. Short sellers, meanwhile, are crowding into the stock, with bets against the tech and cloud giant representing around 92 million shares, or 1.27% of its outstanding float, according to data from S3 Partners.
The Tim Cook era was a highly profitable one for Apple shareholders.
Sofi Technologies (NASDAQ:SOFI) reported second quarter 2026 results that exceeded Wall Street expectations for revenue and adjusted earnings, while raising its full-year revenue outlook as the financial technology company continued to expand its member base and product offerings. The company...
LEU's Q2 report could reflect uranium price gains offset by weaker SWU volumes and rising costs, with earnings and revenues expected to decline year over year.
HII heads into Q2 earnings with sales gains expected across segments, while higher G&A costs may pressure profit.
Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ENPH's Q2 adjusted earnings match estimates, but revenues fall 19.6% as weaker U.S. sales weigh on results.
EIX's Q2 results are likely to reflect grid investments, rate-case support, rising demand and tighter cost controls.
PEP's lower valuation and 4%-plus dividend yield offer support, but margin pressure, high debt and weaker estimates temper the stock's appeal.
GD beats Q2 earnings and revenue estimates as all four segments rise, led by Aerospace and Marine Systems, while cash strengthens.
Verizon Communications (NYSE:VZ) jumped recently after posting earnings. Profit beat estimates and rose year over year, but revenue missed estimates. The stock still trades at a discount to peers, under 9.5 times forward earnings versus roughly 13x for the group. The question is whether that discount is a gift or a warning sign. The Bull […]
LUMN heads into Q2 earnings with AI-driven PCF and NaaS momentum, while legacy declines and heavy debt remain key concerns.

Procter & Gamble (PG) stock takes a dip on Wednesday after missing fourth quarter revenue expectations ($21.2 billion vs. estimates of $21.38 billion). P&G CFO Andre Schulten speaks with Yahoo Finance Executive Editor Brian Sozzi about the latest trends in consumer buying and whether North American shoppers reflect those trends.
Humana’s shares dipped in morning trading after its results compared unfavorably with other insurers’ performance this quarter The Medicare-focused insurer modestly beat analysts’ profit projections, offered reassurance on medical cost trends and left guidance unchanged on an adjusted basis.
Schlumberger beats Q2 earnings and revenue estimates, lifting investor interest in energy ETFs like IEZ, OIH and XLE with heavy exposure to SLB.
ANET heads into Q2 earnings with strong AI networking momentum, rising estimates and a likely beat, though its premium valuation raises the stakes.
Procter & Gamble Co (NYSE:PG, XETRA:PRG) shares fell more than 3% on Wednesday after the consumer goods giant reported fourth-quarter revenue that missed analyst estimates, even as it topped profit expectations. The maker of Tide detergent and Pampers diapers posted revenue of $21.2...
Susquehanna analyst Mehdi Hosseini believes the company’s growth is constrained even as KLA issues an upbeat forecast.
Procter & Gamble's (PG) fiscal fourth-quarter revenue fell short of market estimates on Wednesday, w
Tesla stock has fallen 29.8% year to date, yet the valuation checks still point to a company that screens as expensive rather than obviously cheap on current fundamentals. The share price decline of 29.8% so far this year has reset expectations for Tesla, but not enough to flip the stock into clear bargain territory on standard valuation metrics. Heavy spending on AI, robotics and autonomous driving can support long term revenue ambitions, while the pressure on margins and cash generation...
Earlier this month, Deckers Outdoor reported first-quarter 2026 sales of US$1,019.53 million with net income of US$129.97 million, and raised its full-year fiscal 2027 guidance to net sales of US$5.86–5.91 billion, operating margin slightly above 21.5%, and diluted EPS of US$7.35–7.50, assuming share repurchases equal to roughly 80% of projected free cash flow. Alongside the guidance upgrade, Deckers’ Teva division rolled out an extensive Fall 2026 performance and lifestyle lineup, including...
Cloud computing and online retail behemoth Amazon (NASDAQ:AMZN) will be reporting results this Thursday afternoon. Here’s what you need to know.
Flex (NASDAQ:FLEX) reported first-quarter fiscal 2027 results that included 21% revenue growth, expanding margins and record adjusted earnings per share, while management said the company remains on track to separate its Cloud and Power Infrastructure business into an independent company in the firs
Biogen (NASDAQ:BIIB) reported second-quarter 2026 total revenue of $2.7 billion, up 3% from a year earlier, as growth products and the recently completed acquisition of Apellis contributed to results. Core pharmaceutical revenue rose 4% year over year to $1.8 billion, while the company’s growth port
Shares of Bloom Energy (NYSE:BE) advanced 11% to $185.85 in early Wednesday trading after the fuel cell maker delivered a blowout Q2 2026 earnings beat and raised full-year guidance. The move flipped Tuesday’s pre-earnings selloff, when Bloom Energy shares fell 13% amid short-seller pressure from Hunterbrook. However, BE stock soon retreated to $173.29, up 4% ... Bloom Energy Soars 11% on Record $1.07B Q2 Revenue, Raised 2026 Guidance
It takes a lot for artificial-intelligence trade-related companies to impress Wall Street with earnings or guidance these days, but Teradyne has done just that. Shares of the semiconductor test equipment manufacturer rose 9% to $338.43 on Wednesday after the company late Tuesday reported better-than-expected second-quarter earnings and solid quarterly guidance. Teradyne posted adjusted earnings of $2.47 a share in the second quarter, up from 57 cents a year ago and well above Wall Street’s expectation of $2.09.
MKS (MKSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.